ImmunoPrecise Antibodies (IPA) Institutional Ownership $0.36 -0.03 (-7.44%) (As of 02:45 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$627.64KNumber ofInstitutional Sellers(last 12 months)0 Get IPA Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPA Institutional Buying and Selling by Quarter Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. ImmunoPrecise Antibodies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Ingalls & Snyder LLC1,558,892$996K0.0%+20.3%5.407% 8/9/2024 Renaissance Technologies LLC63,910$65K0.0%+70.0%0.243% 1/29/2024 Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868% 11/13/2023 Rathbones Group PLC14,000$26K0.0%N/A0.056% 11/2/2023 Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105% 8/2/2023 Bank of Montreal Can208,110$668K0.0%N/A0.831% Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 5/9/2023 Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244% 2/1/2023 Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966% 1/31/2023 Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891% 11/7/2022 Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108% 10/21/2022 Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878% 8/12/2022 Ikarian Capital LLC61,433$237K0.0%-20.9%0.247% 8/11/2022 Bank of Montreal Can194,164$801K0.0%+38.2%0.782% 8/10/2022 Cibc World Market Inc.47,427$183K0.0%N/A0.191% 5/9/2022 Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570% 2/11/2022 Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215% 1/31/2022 Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103% 1/24/2022 National Bank of Canada FI7,540$40K0.0%N/A0.039% 11/15/2021 Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906% 11/12/2021 Trexquant Investment LP17,852$111K0.0%N/A0.092% 11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459% 10/27/2021 Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212% 8/25/2021 Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200% 8/16/2021 Marshall Wace LLP36,259$218K0.0%+8.5%0.188% 8/13/2021 Renaissance Technologies LLC17,400$105K0.0%N/A0.090% 8/13/2021 AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070% 8/12/2021 Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065% 8/12/2021 JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358% 8/12/2021 Bank of Montreal Can45,224$285K0.0%+543.8%0.235% 8/5/2021 Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073% 8/3/2021 Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124% 5/17/2021 Ikarian Capital LLC150,000$1.47M0.0%N/A0.783% 5/14/2021Credit Suisse AG33,423$328K0.0%N/A0.174% 5/13/2021 AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494% 5/12/2021 JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231% 5/11/2021 Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021% 4/21/2021 Ingalls & Snyder LLC517,195$5.08M0.2%+30.5%2.705% 2/19/2021 JPMorgan Chase & Co.19,505$292K0.0%N/A0.116% 2/17/2021 Jane Street Group LLC40,774$610K0.0%N/A0.243% Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW2/5/2021 Orion Portfolio Solutions LLC15,821$237K0.0%N/A0.094% 1/27/2021 Ingalls & Snyder LLC396,425$5.93M0.3%N/A2.358% (Data available from 1/1/2016 forward) IPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPA shares? During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($996K), Bank of Montreal Can ($668K), and Renaissance Technologies LLC ($65K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors. What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors? 6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings. Which institutional investors have been buying ImmunoPrecise Antibodies stock? The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($607.45K), Bank of Montreal Can ($221.79K), Renaissance Technologies LLC ($26.31K), and Rathbones Group PLC ($14K). How much institutional buying is happening at ImmunoPrecise Antibodies? Institutional investors have bought a total of 869,549 shares in the last 24 months. This purchase volume represents approximately $1.60M in transactions. Which ImmunoPrecise Antibodies major shareholders have been selling company stock? The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K). How much institutional selling is happening at ImmunoPrecise Antibodies? Institutional investors have sold a total of 31,802 shares in the last 24 months. This volume of shares sold represents approximately $58.20K in transactions. Related Companies Anebulo Pharmaceuticals Major Shareholders Barinthus Biotherapeutics Major Shareholders OS Therapies Major Shareholders CEL-SCI Major Shareholders Lumos Pharma Major Shareholders RAPT Therapeutics Major Shareholders NextCure Major Shareholders Elevation Oncology Major Shareholders Carisma Therapeutics Major Shareholders Lexaria Bioscience Major Shareholders This page (NASDAQ:IPA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
